Sen. Bernie Sanders urged Novo Nordisk to lower U.S. prices for diabetes and weight loss drugs. Denmark struggles to afford these drugs, leading to potential out-of-pocket costs for patients.
Countries face challenges paying for expensive drugs, influenced by U.S. prices. Denmark contemplates patients paying for Ozempic, straining the health system.
Global health systems negotiate drug costs; America sees restrictions in accessing expensive drugs. Patients may face difficulties due to high prices and insurance limitations.
Collection
[
|
...
]